Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perspective: The big C

Literature DB >> 21430710

Perspective: The big C - for Chemoprevention.

Michael B Sporn¹.

Abstract

Mesh：

Year: 2011 PMID： 21430710 DOI： 10.1038/471S10a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

10 in total

1. Third-generation SERMs may face uphill battle.

Authors: Charlie Schmidt
Journal: J Natl Cancer Inst Date: 2010-11-08 Impact factor: 13.506

Review 2. Dichotomies in cancer research: some suggestions for a new synthesis.

Authors: Michael B Sporn
Journal: Nat Clin Pract Oncol Date: 2006-07

3. Effect of dutasteride on the risk of prostate cancer.

Authors: Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal: N Engl J Med Date: 2010-04-01 Impact factor: 91.245

4. Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.

Authors: Andrea Z LaCroix; Trevor Powles; C Kent Osborne; Kevin Wolter; John R Thompson; David D Thompson; D Craig Allred; Róisín Armstrong; Steve R Cummings; Richard Eastell; Kristine E Ensrud; Paul Goss; Andrew Lee; Patrick Neven; David M Reid; Madelyn Curto; Slobodan Vukicevic
Journal: J Natl Cancer Inst Date: 2010-11-04 Impact factor: 13.506

Review 5. The tumour microenvironment as a target for chemoprevention.

Authors: Adriana Albini; Michael B Sporn
Journal: Nat Rev Cancer Date: 2007-02 Impact factor: 60.716

6. Time to think outside the (genetic) box.

Authors: Jean-Pierre J Issa; Judy E Garber
Journal: Cancer Prev Res (Phila) Date: 2011-01

7. Cancer statistics, 2010.

Authors: Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal: CA Cancer J Clin Date: 2010-07-07 Impact factor: 508.702

8. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.

Authors: U Veronesi; L Mariani; A Decensi; F Formelli; T Camerini; R Miceli; M G Di Mauro; A Costa; E Marubini; M B Sporn; G De Palo
Journal: Ann Oncol Date: 2006-05-04 Impact factor: 32.976

9. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

Authors: Frank L Meyskens; Christine E McLaren; Daniel Pelot; Sharon Fujikawa-Brooks; Philip M Carpenter; Ernest Hawk; Gary Kelloff; Michael J Lawson; Jayashri Kidao; John McCracken; C Gregory Albers; Dennis J Ahnen; D Kim Turgeon; Steven Goldschmid; Peter Lance; Curt H Hagedorn; Daniel L Gillen; Eugene W Gerner
Journal: Cancer Prev Res (Phila) Date: 2008-06

10. A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors: Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal: Nature Date: 2009-12-16 Impact factor: 49.962

10 in total

15 in total

1. CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

Authors: Eun-Hee Kim; Chuxia Deng; Michael B Sporn; Darlene B Royce; Renee Risingsong; Charlotte R Williams; Karen T Liby
Journal: Cancer Prev Res (Phila) Date: 2011-09-20

2. miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

Authors: Emanuel Kronski; Micol E Fiori; Ottavia Barbieri; Simonetta Astigiano; Valentina Mirisola; Peter H Killian; Antonino Bruno; Arianna Pagani; Francesca Rovera; Ulrich Pfeffer; Christian P Sommerhoff; Douglas M Noonan; Andreas G Nerlich; Laura Fontana; Beatrice E Bachmeier
Journal: Mol Oncol Date: 2014-01-16 Impact factor: 6.603

3. In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors: Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Kong
Journal: AAPS J Date: 2017-12-20 Impact factor: 4.009

Review 4. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

Authors: Gagan Deep; Rajesh Agarwal
Journal: Curr Cancer Drug Targets Date: 2013-06 Impact factor: 3.428

5. The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.

Authors: Ana S Leal; Michael B Sporn; Patricia A Pioli; Karen T Liby
Journal: Carcinogenesis Date: 2016-09-22 Impact factor: 4.944

6. Correction to: In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors: Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Tony Kong
Journal: AAPS J Date: 2018-02-06 Impact factor: 4.009